Short Interest in First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Grows By 275.0%

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,500 shares, an increase of 275.0% from the December 15th total of 400 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is currently 0.6 days.

First Trust Nasdaq Pharmaceuticals ETF Price Performance

Shares of NASDAQ:FTXH traded down $0.31 during trading on Tuesday, hitting $26.88. 710 shares of the company were exchanged, compared to its average volume of 1,014. The firm’s 50 day moving average price is $27.68 and its 200-day moving average price is $28.24. First Trust Nasdaq Pharmaceuticals ETF has a 12-month low of $25.73 and a 12-month high of $29.72. The stock has a market capitalization of $14.78 million, a P/E ratio of 15.98 and a beta of 0.70.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Tuesday, December 31st. Shareholders of record on Friday, December 13th were paid a $0.1304 dividend. The ex-dividend date of this dividend was Friday, December 13th. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous dividend of $0.13.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.